Dextran sulphate inhibits an association of prions with plasma membrane at the early phase of infection.
Abnormal prion protein
Cellular prion protein
Endocytosis
Lipid rafts
Prion diseases
Journal
Neuroscience research
ISSN: 1872-8111
Titre abrégé: Neurosci Res
Pays: Ireland
ID NLM: 8500749
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
24
07
2020
revised:
29
12
2020
accepted:
14
01
2021
pubmed:
22
1
2021
medline:
7
9
2021
entrez:
21
1
2021
Statut:
ppublish
Résumé
The defining characteristic of prion diseases is conversion of a cellular prion protein (PrP
Identifiants
pubmed: 33476681
pii: S0168-0102(21)00018-3
doi: 10.1016/j.neures.2021.01.004
pii:
doi:
Substances chimiques
PrPSc Proteins
0
Prions
0
Dextran Sulfate
9042-14-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
34-40Informations de copyright
Copyright © 2021 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have no conflicts of interest to declare.